Xiaoyang Qi

Professor

University of Cincinnati

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Xiaoyang Qi is a faculty member at the University of Cincinnati in the United States. His research primarily focuses on cancer biology, with particular emphasis on therapeutic and diagnostic applications of phosphatidylserine, glioblastoma treatment, and the mechanisms of autophagy in tumor progression. Recent publications highlight innovative approaches using nanovesicles for targeted therapies in various cancers.

Articles (10)

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Wen-Hai Shao

Associate Professor

University of Cincinnati

UNITED STATES

View details

Atsuo Sasaki

Project Professor

Hiroshima University Hospital

JAPAN

View details

Jing-Huei Lee

Professor and Graduate Studies Director

University of Cincinnati

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Xiaoyang Qi

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Axl Expression in Renal Mesangial Cells Is Regulated by Sp1, Ap1, MZF1, and Ep300, and the IL-6/miR-34a Pathway

Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy

Reuse of Molecules for Glioblastoma Therapy

SapC–DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents

Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer.

Autophagy mediated lipid catabolism facilitates glioma progression to overcome bioenergetic crisis.

Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.

Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer.

Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease.

SapC-DOPS - a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy.

Collaborators (3)

Wen-Hai Shao

Atsuo Sasaki

Jing-Huei Lee

Make your next move.

Xiaoyang Qi

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Axl Expression in Renal Mesangial Cells Is Regulated by Sp1, Ap1, MZF1, and Ep300, and the IL-6/miR-34a Pathway

Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy

Reuse of Molecules for Glioblastoma Therapy

SapC&ndash;DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents

Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer.

Autophagy mediated lipid catabolism facilitates glioma progression to overcome bioenergetic crisis.

Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.

Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer.

Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease.

SapC-DOPS - a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy.

Collaborators (3)

Wen-Hai Shao

Atsuo Sasaki

Jing-Huei Lee

Make your next move.

SapC–DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents